×

Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC, Keum KC. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol. 2010 May 27;5:43.

Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim DY. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1343-51

Koom WS, Choi Y, Shim SJ, Cha J, Seong J, Kim NK, Nam KC, Keum KC. Reirradiation to the pelvis for recurrent rectal cancer. J Surg Oncol. 2012 Jun 1;105(7):637-42

Cha J, Seong J, Keum KC, Lee CG, Koom WS. Comparison of elective inguinal node irradiation techniques in anal cancer. Radiat Oncol J. 2011 Dec;29(4):236-42.

Cha J, Seong J, Lee IJ, Kim JW, Han KH. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013 Sep;54(5):1178-85

Jihye C, Jinsil S. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma. Liver Cancer. 2012 Nov;1(3-4):216-25

Cha J, Suh CO, Park K, Chang JH, Lee KS, Kim SH, Chang JS, Kim JH, Suh YG, Kim JW, Cho J. Feasibility and outcomes of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy for malignant gliomas: a preliminary report. Yonsei Med J. 2014 Jan;55(1):70-7.

Chang H, Shin SK, Cho BC, Lee CG, Kim CB, Kim DJ, Lee JG, Hur J, Lee CY, Bae MK, Kim HR, Lee SK, Park JC, Lee H, Kim HI, Chung H, Cha J, Lee YC, Kim JH. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.Cancer Chemother Pharmacol. 2014 Apr;73(4):665-71

Suh YG, Lee IJ, Koom WS, Cha J, Lee JY, Kim SK, Lee CG. High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer. Jpn J Clin Oncol. 2014 Jun;44(6):534-40

Kim HM, Lee KJ, Cha J, Chung MJ, Bang S, Seong J, Song SY, Park SW. A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer. Cancer Chemother Pharmacol. 2014 Oct;74(4):861-5.

Han HJ, Kim MS, Cha J, Choi JS, Han KH, Seong J. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma. Oncology. 2014;87 Suppl 1:82-9.

Yoon HI, Cha J, Keum KC, Lee HY, Nam EJ, Kim SW, Kim S, Kim YT, Kim GE, Kim YB. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis. Radiat Oncol. 2015 Jan 13;10:18.

Kang MK, Oh D, Cho KH, Moon SH, Wu HG, Heo DS, Ahn YC, Park K, Park HJ, Park JS, Keum KC, Cha J, Kim JW, Kim YS, Kang JH, Oh YT, Kim JY, Kim SH, Kim JH, Lee CG. Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy. Cancer Res Treat. 2015 Oct;47(4):871-8.

Yoon MS, Park W, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Chang SK, Lee KK, Kim M. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17). Gynecol Oncol. 2015 Sep;138(3):519-25.

Cha J, Jeon TW, Lee CG, Oh ST, Yang HB, Choi KJ, Seo D, Yun I, Baik IH, Park KR, Park YN, Lee YH. Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis. Int J Hyperthermia. 2015;31(7):784-92.

Park K, Lee Y, Cha J, You SH, Kim S, Lee JY. Influence of different boost techniques on radiation dose to the left anterior descending coronary artery. Radiat Oncol J. 2015 Sep;33(3):242-9.

Yoon MS, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Lee KK, Kim M, Jeong JU, Chang SK, Park W. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma. Cancer Res Treat. 2016 Jul;48(3):1074-83.

Song JH, Wu HG, Keam BS, Hah JH, Ahn YC, Oh D, Noh JM, Park HJ, Lee CG, Keum KC, Cha J, Cho KH, Moon SH, Kim JY, Chung WK, Oh YT, Kim WT, Cho MJ, Kay CS, Kim YS. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis. Cancer Res Treat. 2016 Jul;48(3):917-27.

Cha J, Kim YS, Park W, Kim HJ, Kim JY, Kim JH, Kim J, Yoon WS, Kim JW, Kim YB. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08). J Gynecol Oncol. 2016 Jul 11:e58.

Lee KJ, Yi SW, Cha J, Seong J, Bang S, Song SY, Kim HM, Park SW. A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer. Cancer Chemother Pharmacol. 2016 Oct;78(4):841-6.

Yoon MS, Park W, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim J-Y, Lee J-H, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun J, Choi Y, Chang SK, Lee KK, Kim M, Jeong J-U, Nam T-K. Impact of paraaortic lymphadenopathy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group Study (KROG 13-17). ESJO 2016 Oct 42:1497-1505